+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoinjectors Global Market Report 2021: COVID-19 Implications and Growth

  • ID: 5437912
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Biogen
  • Eli Lilly and Company
This report provides the strategists, marketers and senior management with the critical information they need to assess the global autoinjectors market.







The report focuses on the autoinjectors market which is experiencing strong growth. It gives a guide to the autoinjectors market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for autoinjectors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Autoinjectors market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider autoinjectors market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The autoinjectors market section of the report gives context. It compares the autoinjectors market with other segments of the autoinjectors market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, autoinjectors indicators comparison.

Scope


Markets Covered:


  • By Type: Disposable Autoinjectors; Reusable Autoinjectors
  • By Therapy: Rheumatoid Arthritis; Multiple Sclerosis; Diabetes; Anaphylaxis; Other Therapies
  • By Route Of Administration: Subcutaneous; Intramuscular
  • By Distribution Channel: Online Retailer; Pharmacy
  • By End User: Home Care Settings; Hospitals and Clinics; Others

Companies Mentioned:


  • AbbVie; Mylan; Eli Lilly and Company; Amgen; Becton, Dickinson and Company

Countries:


  • Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


  • Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


  • Five years historic and ten years forecast.

Data:


  • Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations:


  • Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


  • Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Autoinjectors Market

What is the estimated value of the Global Autoinjectors Market?

The Global Autoinjectors Market was estimated to be valued at $2.9 billion in 2021.

What is the growth rate of the Global Autoinjectors Market?

The growth rate of the Global Autoinjectors Market is 19.3%, with an estimated value of $6.0 billion by 2025.

What is the forecasted size of the Global Autoinjectors Market?

The Global Autoinjectors Market is estimated to be worth $6.0 billion by 2025.

Who are the key companies in the Global Autoinjectors Market?

Key companies in the Global Autoinjectors Market include AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck and Bayer.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Biogen
  • Eli Lilly and Company

1. Executive Summary2. Autoinjectors Market Characteristics3. Autoinjectors Market Trends and Strategies4. Impact Of COVID-19 On Autoinjectors
5. Autoinjectors Market Size and Growth
5.1. Global Autoinjectors Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Autoinjectors Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Autoinjectors Market Segmentation
6.1. Global Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Disposable Autoinjectors
  • Reusable Autoinjectors
6.2. Global Autoinjectors Market, Segmentation by therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other therapies
6.3. Global Autoinjectors Market, Segmentation by Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Subcutaneous
  • Intramuscular
6.4. Global Autoinjectors Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Online Retailer
  • Pharmacy
6.5. Global Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Home Care Settings
  • Hospitals and Clinics
  • Others

7. Autoinjectors Market Regional and Country Analysis
7.1. Global Autoinjectors Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Autoinjectors Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Autoinjectors Market
8.1. Asia-Pacific Autoinjectors Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Autoinjectors Market
9.1. China Autoinjectors Market Overview
9.2. China Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Autoinjectors Market
10.1. India Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Autoinjectors Market
11.1. Japan Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Autoinjectors Market
12.1. Australia Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Autoinjectors Market
13.1. Indonesia Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Autoinjectors Market
14.1. South Korea Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Autoinjectors Market
15.1. Western Europe Autoinjectors Market Overview
15.2. Western Europe Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Autoinjectors Market
16.1. UK Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Autoinjectors Market
17.1. Germany Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Autoinjectors Market
18.4. France Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Autoinjectors Market
19.1. Eastern Europe Autoinjectors Market Overview
19.2. Eastern Europe Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Autoinjectors Market
20.1. Russia Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Autoinjectors Market
21.1. North America Autoinjectors Market Overview
21.2. North America Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Autoinjectors Market
22.1. USA Autoinjectors Market Overview
22.2. USA Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Autoinjectors Market
23.1. South America Autoinjectors Market Overview
23.2. South America Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Autoinjectors Market
24.1. Brazil Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Autoinjectors Market
25.1. Middle East Autoinjectors Market Overview
25.2. Middle East Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Autoinjectors Market
26.1. Africa Autoinjectors Market Overview
26.2. Africa Autoinjectors Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Autoinjectors Market, Segmentation by End User , Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Autoinjectors Market Competitive Landscape and Company Profiles
27.1. Autoinjectors Market Competitive Landscape
27.2. Autoinjectors Market Company Profiles
27.2.1. AbbVie
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Mylan
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Eli Lilly and Company
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Amgen
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Becton Dickinson and Company
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Autoinjectors Market29. Autoinjectors Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Biogen
  • Eli Lilly and Company
Major players in the autoinjectors market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen, and AstraZeneca.

The global autoinjectors market is expected to grow from $2.42 billion in 2020 to $2.94 billion in 2021 at a compound annual growth rate (CAGR) of 21.3%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $5.95 billion in 2025 at a CAGR of 19.3%.

The autoinjectors market consists of sales of auto-injectors by entities (organizations, sole traders, and partnerships) that are designed to help people overcome their fear of using a needle-based medication delivery system on their own. An autoinjector is a device for injecting a single, preset dose of medication into one's own body. It generally consists of a spring-loaded syringe that is activated when the device is pressed firmly against the body.

The main types of autoinjectors are disposable autoinjectors and reusable autoinjectors. The disposable autoinjectors market consists of sales of disposable autoinjectors by entities (organizations, sole traders, and partnerships) that are designed to replace traditional pre-filled syringes and eliminate psychological barriers by removing the needle from the patient's view. Disposable autoinjectors combine a spring-powered power source with a protected needle that administers the required drug solution subcutaneously or intramuscularly. The different therapies include rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, other therapies and are administered in various routes such as subcutaneous, intramuscular. These are sold to customers through an online retailer and pharmacy and are implemented in various verticals such as home care settings, hospitals and clinics, others.

North America was the largest region in the autoinjectors market in 2020. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The growing technological advancements are shaping the autoinjectors market. Major players operating in the autoinjectors sector are focused on developing technological solutions for autoinjectors to meet the demand for a viscous biologics delivery mechanism. For instance, in February 2021, Becton Dickinson (BD), a US-based medical device company is developing Intevia 2.25 mL based on thinner wall cannula technology. The Intevia 2.25 mL is a patient-centric device that works seamlessly with BD Neopak XtraFlow prefillable syringes and has an 8-millimeter needle with a thinner wall.

In March 2020, SHL medical, a Switzerland-based provider of advanced delivery devices, such as autoinjectors, pen injectors, advanced inhalers, and wearable drug delivery systems, acquired Weibel CDS for an undisclosed amount. Through this acquisition, SHL is expected to expand its portfolio of innovative drug delivery solutions for injection devices. Weibel CDS is a Swiss medical technology company that specializes in the research and development of patch injection systems and devices.

The increasing prevalence of chronic diseases is expected to fuel the growth of the autoinjectors market in the coming years. Chronic diseases are described as illnesses that last a year or longer and necessitate continuing medical attention. Chronic diseases such as heart disease, cancer, rheumatoid arthritis, and diabetes are the world's top causes of mortality and disability. Auto injection devices are intended for multiple injections of biologics and hormones in patients who require regular dosage for long-term management of medical circumstances such as diabetes and rheumatoid arthritis. For instance, according to the Imperial College London research in 2020, chronic diseases are expected to kill almost 41 million people globally each year, accounting for seven out of ten fatalities. Around 17 million of these fatalities are classified as premature, with people dying substantially younger than predicted on average. Therefore, the increasing prevalence of chronic diseases drives the growth of the autoinjectors market.

The countries covered in the autoinjectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AbbVie
  • Mylan
  • Eli Lilly and Company
  • Amgen
  • Becton, Dickinson and Company
  • Johnson & Johnson
  • Teva Pharmaceutical
  • Merck
  • Pfizer
  • Bayer
  • Biogen
  • AstraZeneca
Note: Product cover images may vary from those shown

Loading
LOADING...